An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome
- PMID: 31399558
- PMCID: PMC6689064
- DOI: 10.1038/s41408-019-0226-4
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome
Abstract
Patients with multiple myeloma (MM) accumulate adverse copy number aberrations (CNAs), gains of 1q21, and 17p deletions during disease progression. A subset of these patients develops heightened 1q12 pericentromeric instability and jumping translocations of 1q12 (JT1q12), evidenced by increased copy CNAs of 1q21 and losses in receptor chromosomes (RC). To understand the progression of these aberrations we analyzed metaphase cells of 50 patients with ≥4 CNAs of 1q21 by G-banding, locus specific FISH, and spectral karyotyping. In eight patients with ≥5 CNAs of 1q21 we identified a chromosome instability phenotype similar to that found in ICF syndrome (immunodeficiency, centromeric instability, and facial anomalies). Strikingly, the acquired instability phenotype identified in these patients demonstrates the same transient structural aberrations of 1q12 as those found in ICF syndrome, suggesting similar underlying pathological mechanisms. Four types of clonal aberrations characterize this phenotype including JT1q12s, RC deletions, 1q12-21 breakage-fusion-bridge cycle amplifications, and RC insertions. In addition, recurring transient aberrations include 1q12 decondensation and breakage, triradials, and 1q micronuclei. The acquired self-propagating mobile property of 1q12 satellite DNA drives the continuous regeneration of 1q12 duplication/deletion events. For patients demonstrating this instability phenotype, we propose the term "Jumping 1q Syndrome."
Conflict of interest statement
The authors declare no competing financial interests.
Figures






Similar articles
-
Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma.Blood. 2015 Jun 11;125(24):3756-9. doi: 10.1182/blood-2015-03-632075. Epub 2015 May 5. Blood. 2015. PMID: 25943786 Free PMC article.
-
Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease.Blood. 2014 Apr 17;123(16):2504-12. doi: 10.1182/blood-2013-12-546077. Epub 2014 Feb 4. Blood. 2014. PMID: 24497533 Free PMC article.
-
Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1q.Genes Chromosomes Cancer. 2005 Jan;42(1):95-106. doi: 10.1002/gcc.20109. Genes Chromosomes Cancer. 2005. PMID: 15472896
-
Chromosome 1 instability in multiple myeloma: Aberrant gene expression, pathogenesis, and potential therapeutic target.FASEB J. 2022 Jun;36(6):e22341. doi: 10.1096/fj.202200354. FASEB J. 2022. PMID: 35579877 Review.
-
Chromosome 1q21 abnormalities in multiple myeloma.Blood Cancer J. 2021 Apr 29;11(4):83. doi: 10.1038/s41408-021-00474-8. Blood Cancer J. 2021. PMID: 33927196 Free PMC article. Review.
Cited by
-
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients.Eur J Haematol. 2025 Jul;115(1):16-28. doi: 10.1111/ejh.14413. Epub 2025 Mar 19. Eur J Haematol. 2025. PMID: 40103518 Free PMC article.
-
Chromothripsis as a pathogenic driver of multiple myeloma.Semin Cell Dev Biol. 2022 Mar;123:115-123. doi: 10.1016/j.semcdb.2021.04.014. Epub 2021 May 3. Semin Cell Dev Biol. 2022. PMID: 33958284 Free PMC article. Review.
-
Jumping translocations of chromosome 1q occurring by a multi-stage process in an acute myeloid leukemia progressed from myelodysplastic syndrome with a TET2 mutation.Mol Cytogenet. 2019 Nov 19;12:47. doi: 10.1186/s13039-019-0460-2. eCollection 2019. Mol Cytogenet. 2019. PMID: 31827620 Free PMC article.
-
Drug Targeting of Genomic Instability in Multiple Myeloma.Front Genet. 2020 Apr 9;11:228. doi: 10.3389/fgene.2020.00228. eCollection 2020. Front Genet. 2020. PMID: 32373151 Free PMC article. Review.
-
A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease Complexity.Hemasphere. 2020 Nov 24;4(6):e502. doi: 10.1097/HS9.0000000000000502. eCollection 2020 Dec. Hemasphere. 2020. PMID: 33283171 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical